
    
      The main objective is to describe the effectivity of LIBICARE® in the improvement of desire
      and sexual arousal in women between 45 and 65 years old, in real life.

      The secondary objectives of the study are:

        -  Evaluation of the 6 domains of the EVAS-M scale at 2 and 4 months of treatment.

        -  Assessment of the safety of LIBICARE® by collecting serious and non-serious adverse
           events.

        -  Evaluation of patient satisfaction with treatment at 2 and 4 months of treatment.

        -  Therapeutic compliance in taking the food supplement at 2 and 4 months of treatment.

        -  Study of the hormonal variation in relation to the values of total testosterone, free
           testosterone and SHBG, at the beginning, at 2 months and at 4 months of treatment, in
           those patients in which it is determined by routine clinical practice.

        -  To evaluate the degree of usefulness of the EVAS-M scale in clinical practice after 4
           months of treatment.
    
  